Boiron SA Revenue vs. Current Valuation
| BON Stock | EUR 26.10 0.35 1.32% |
For Boiron SA profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Boiron SA to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Boiron SA utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Boiron SA's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Boiron SA over time as well as its relative position and ranking within its peers.
Boiron |
Boiron SA Current Valuation vs. Revenue Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Boiron SA's current stock value. Our valuation model uses many indicators to compare Boiron SA value to that of its competitors to determine the firm's financial worth. Boiron SA is the top company in revenue category among its peers. It also is the top company in current valuation category among its peers reporting about 1.25 of Current Valuation per Revenue. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Boiron SA's earnings, one of the primary drivers of an investment's value.Boiron Revenue vs. Competition
Boiron SA is the top company in revenue category among its peers. Market size based on revenue of Drug Manufacturers - Major industry is currently estimated at about 5.86 Billion. Boiron SA holds roughly 455.2 Million in revenue claiming about 8% of equities under Drug Manufacturers - Major industry.
Boiron Current Valuation vs. Revenue
Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Boiron SA |
| = | 455.2 M |
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Boiron SA |
| = | 567.45 M |
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
Boiron Current Valuation vs Competition
Boiron SA is the top company in current valuation category among its peers. After adjusting for long-term liabilities, total market size of Drug Manufacturers - Major industry is currently estimated at about 17.44 Billion. Boiron SA holds roughly 567.45 Million in current valuation claiming about 3% of equities under Drug Manufacturers - Major industry.
Boiron SA Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Boiron SA, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Boiron SA will eventually generate negative long term returns. The profitability progress is the general direction of Boiron SA's change in net profit over the period of time. It can combine multiple indicators of Boiron SA, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Boiron SA manufactures and sells homeopathic medicines in France, rest of Europe, North America, and internationally. Boiron SA was founded in 1932 and is headquartered in Messimy, France. BOIRON SA operates under Drug Manufacturers - Major classification in Germany and is traded on Frankfurt Stock Exchange. It employs 3084 people.
Boiron Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Boiron SA. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Boiron SA position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Boiron SA's important profitability drivers and their relationship over time.
Use Boiron SA in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Boiron SA position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Boiron SA will appreciate offsetting losses from the drop in the long position's value.Boiron SA Pair Trading
Boiron SA Pair Trading Analysis
The ability to find closely correlated positions to Boiron SA could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Boiron SA when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Boiron SA - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Boiron SA to buy it.
The correlation of Boiron SA is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Boiron SA moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Boiron SA moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Boiron SA can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Boiron SA position
In addition to having Boiron SA in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Compulsion Thematic Idea Now
Compulsion
Companies involved in research, development, and manufacturing of products with compulsion characteristics such as cigarettes, addictive drugs and alcohol. The Compulsion theme has 40 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Compulsion Theme or any other thematic opportunities.
| View All Next | Launch |
Other Information on Investing in Boiron Stock
To fully project Boiron SA's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Boiron SA at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Boiron SA's income statement, its balance sheet, and the statement of cash flows.